[HTML][HTML] Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease

…, G Su, J Pak, K Zelenakas, M Luchi… - … England Journal of …, 2005 - Mass Medical Soc
Background The advent of bisphosphonates advanced therapy for Paget's disease, but
more effective and convenient agents are needed to increase adherence. Zoledronic acid, a …

[HTML][HTML] Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate

…, CH Lee, RK Fidelus-Gort, ME Luchi… - Annals of the …, 2015 - ard.bmj.com
Objectives To investigate baricitinib (LY3009104, formerly INCB028050), a novel, oral
inhibitor of JAK1/JAK2 in patients with moderate to severe rheumatoid arthritis (RA) despite …

Comparison of radiographic joint space width with magnetic resonance imaging cartilage morphometry: analysis of longitudinal data from the Osteoarthritis Initiative

…, MPH Le Graverand, M Luchi… - Arthritis care & …, 2010 - Wiley Online Library
Objective Magnetic resonance imaging (MRI) and radiography are established imaging
modalities for the assessment of knee osteoarthritis (OA). The objective of our study was to …

Change in cartilage morphometry: a sample of the progression cohort of the Osteoarthritis Initiative

…, R Davies, MPH Le Graverand, M Luchi… - Annals of the …, 2009 - ard.bmj.com
Objective: The performance characteristics of hyaline articular cartilage measurement on
magnetic resonance imaging (MRI) need to be accurately delineated before widespread …

A randomized, double-blind, placebo-controlled, dose-escalation study of the safety and efficacy of INCB039110, an oral janus kinase 1 inhibitor, in patients with …

R Bissonnette, M Luchi, R Fidelus-Gort… - Journal of …, 2016 - Taylor & Francis
Background: Chronic plaque psoriasis is partially mediated by elevation of proinflammatory
cytokines, including several within the Janus kinase/signal transducer and activator of …

JAK inhibition for the treatment of rheumatoid arthritis: a new era in oral DMARD therapy

K Vaddi, M Luchi - Expert opinion on investigational drugs, 2012 - Taylor & Francis
Introduction: In rheumatoid arthritis (RA) there is a significant medical need for safe and
effective oral disease-modifying anti-rheumatic drugs (DMARDs) for patients who respond …

Primary idiopathic pulmonary hypertension complicated by pulmonary arterial thrombosis. Association with antiphospholipid antibodies

ME Luchi, RA Asherson… - Arthritis & Rheumatism …, 1992 - Wiley Online Library
Objective. We report an unusual case of primary pulmonary hypertension and review the
pertinent literature. Methods. A 25‐year‐old Caucasian woman presented with progressive …

MRI and dose selection in a phase II trial of baricitinib with conventional synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis

…, DE Schlichting, SD Beattie, M Luchi… - The Journal of …, 2019 - jrheum.org
Objective. Magnetic resonance imaging (MRI) was used in a phase IIb study of baricitinib in
patients with RA to support dose selection for the phase III program. Methods. Three …

Detection of T cell receptors in early rheumatoid arthritis synovial tissue

T Ramanujam, M Luchi, R Schumacher, S Zwillich… - Pathobiology, 1995 - karger.com
Synovial tissue is rarely available from patients with early synovitis, with the exception of
synovial biopsies. However, T cell populations early in the development of synovitis may be …

[HTML][HTML] Comparison of radiographic joint space width to MRI cartilage morphometry: analysis of longitudinal data from the Osteoarthritis Initiative (OAI)

…, C Dabrowski, MPH Le Graverand, M Luchi… - Arthritis care & …, 2010 - ncbi.nlm.nih.gov
METHODS This study examined the baseline and 12 month visits of a subset of 150 subjects
from the OAI. Measurement of radiographic JSW was facilitated by the use of automated …